Literature DB >> 6895465

Studies on the mechanism of action of 6-mercaptopurine. Interaction with copper and xanthine oxidase.

U Kela, R Vijayvargiya.   

Abstract

Interaction between 6-mercaptopurine, Cu2+ and the enzyme xanthine oxidase (EC 1.2.3.2.) was examined. Whereas Cu2+ was found to inhibit the enzyme, 6-mercaptopurine could protect as well as reverse the enzyme inhibition produced by the metal ion. The formation of a complex between 6-mercaptopurine and Cu2+ seems to be responsible for the observed effect. Job's [(1928) Ann. Chem. 9, 113] method has shown the composition of the complex to be 1:1. The apparent stability constant (log K value), as determined by Subhrama Rao & Raghav Rao's [(1955) J. Sci. Chem. Ind. Res. 143, 278], method is found to be 6.74. It is suggested that the formation of a stable complex between 6-mercaptopurine molecules and Cu2+ may be an additional mechanism of action of 6-mercaptopurine, particularly with reference to its anti-inflammatory properties.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6895465      PMCID: PMC1162669          DOI: 10.1042/bj1930799

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Chemical suppression of the immune response.

Authors:  G H HITCHINGS; G B ELION
Journal:  Pharmacol Rev       Date:  1963-06       Impact factor: 25.468

2.  The chemistry of xanthine oxidase. The problems of enzyme inactivation and stabilization.

Authors:  F BERGEL; R C BRAY
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

3.  Treatment of ulcerative colitis with antimetabolites.

Authors:  R H Bean
Journal:  Br Med J       Date:  1966-04-30

4.  Effect of 6-mercaptopurine on inflammation.

Authors:  A R PAGE; R M CONDIE; R A GOOD
Journal:  Am J Pathol       Date:  1962-05       Impact factor: 4.307

5.  Copper and primary biliary cirrhosis.

Authors:  C R Fleming; E R Dickson; A H Baggenstoss; J T McCall
Journal:  Gastroenterology       Date:  1974-12       Impact factor: 22.682

6.  Letter: Anti-inflammatory drugs and tissue copper.

Authors:  M E Elmes
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

7.  Serum copper levels in lymphoma and leukemia. Special reference to Hodgkin's disease.

Authors:  M Hrgovcic; C F Tessmer; T M Minckler; B Mosier; G H Taylor
Journal:  Cancer       Date:  1968-04       Impact factor: 6.860

8.  Serum copper observations in patients with malignant lymphoma.

Authors:  M Hrgovcic; C F Tessmer; F B Thomas; P S Ong; J F Gamble; C C Shullenberger
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

9.  Studies on milk xanthine oxidase. Some spectral and kinetic properties.

Authors:  V Massey; P E Brumby; H Komai
Journal:  J Biol Chem       Date:  1969-04-10       Impact factor: 5.157

10.  Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2).

Authors:  N Prajda; H P Morris; G Weber
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

View more
  2 in total

1.  Redox cycling of Cu(II) by 6-mercaptopurine leads to ROS generation and DNA breakage: possible mechanism of anticancer activity.

Authors:  Sayeed Ur Rehman; Haseeb Zubair; Tarique Sarwar; Mohammed Amir Husain; Hassan Mubarak Ishqi; Shamshun Nehar; Mohammad Tabish
Journal:  Tumour Biol       Date:  2014-10-25

2.  Analyses of the combination of 6-MP and dasatinib in cell culture.

Authors:  Gurmeet Kaur; Holger Behrsing; Ralph E Parchment; Myrtle Davis Millin; Beverly A Teicher
Journal:  Int J Oncol       Date:  2013-05-02       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.